Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/1998
06/03/1998CN1183722A Use of penciclovir for treatment of human herpes-virus-8
06/03/1998CN1183292A Antioncotic antalgesic Zanthoxylum nitidum tablet
06/03/1998CN1038586C Process for preparing pyrazine derivs
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760186 Inflammatory cytokine, diagnosis and therapy
06/02/1998US5760084 Treating dermatological disorders
06/02/1998US5760068 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/02/1998US5760046 oral low daily dosage of FINASTERIDE; treating female hirsutism; promoting hair growth; hyperandrogenic conditions of acne vulgaris, seborrhea, polycystic ovary syndrome
06/02/1998US5760035 Piperidine compounds substituted with an aminoalkyl group and an aryloxyalkyl group, antiallergens, antiinflammatory agents, immunosuppressants
06/02/1998US5760027 Use of 7-alkylidene cephalosporins to inhibit elastase activity
06/02/1998US5760018 Treatment of pain, inflammation, migraine, emesis
06/02/1998US5760002 Analgesics
06/02/1998US5759804 Culture product
06/02/1998US5759583 Polylactic/glycolic acid copolymer, bioactive agent and quaternary ammonium surfactant
06/02/1998US5759546 Treatment of CD4 T-cell mediated conditions
06/02/1998US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses
06/02/1998US5759533 Neutrophil-activating peptide-2
06/02/1998CA2158632C Catechol diether compounds as inhibitors of tnf release
06/02/1998CA2019013C Process to improve the therapeutic efficacy of fat-soluble corticosteroids and composition for the application of this process
05/1998
05/28/1998WO1998022583A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION
05/28/1998WO1998022501A2 Secreted proteins and polynucleotides encoding them
05/28/1998WO1998022500A2 Modulation of interactions between myosin and integrins
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022458A1 Multivalent salts of pyridostigmine and related compounds
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998022418A1 Substituted phenols and thiophenols useful as antioxidant agents
05/28/1998WO1998022138A1 Method for treating symptoms of diabetes
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998WO1998016551A3 Variants of vascular endothelial cell growth factor having antagonistic properties
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998CA2633660A1 Method for treating symptoms of diabetes
05/28/1998CA2272050A1 Secreted proteins and polynucleotides encoding them
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2271954A1 Identification of bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction
05/28/1998CA2271786A1 Multivalent salts of pyridostigmine and related compounds
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/27/1998EP0843565A1 Coarse spray delivery of functional biologic materials
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0687268B1 Spiroazacyclic derivatives as substance p antagonists
05/27/1998EP0666861B1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
05/27/1998CN1183043A Preparation and use of sulfated oligosaccharides
05/27/1998CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
05/26/1998US5756764 Drug; proteasome inhibitors
05/26/1998US5756733 Vitamin D amide derivatives
05/26/1998US5756546 Water-soluble nimesulide salt and its preparation, aqueous dolution containing it, nimesulide-based combinations and their uses
05/26/1998US5756530 3,4-substituted pyrazoles for the treatment of inflammation
05/26/1998US5756529 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
05/26/1998US5756520 Compounds with analgesic and local anaesthetic effect
05/26/1998US5756503 Analgesics, anesthetics, antiinflammatory agents
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756485 Silicone-containing derivatives of salicylic acid which have desquamating properties
05/26/1998US5756466 Inhibitors of interleukin-1β converting enzyme
05/26/1998US5756465 Protease enzyme inhibitors
05/26/1998US5756125 Immediate and delayed analgesic therapy
05/26/1998US5756095 Immunoassays for detection of adhesion molecules
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity
05/22/1998WO1998021207A1 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
05/22/1998WO1998021186A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998WO1998020868A1 Guanylhydrazones useful for treating diseases associated with t cell activation
05/22/1998WO1998020852A1 Pharmaceutical compositions containing kukui nut oil
05/22/1998CA2271116A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2270871A1 Peptide compounds useful for modulating fgf receptor activity
05/20/1998EP0843011A2 RsbU-1 derived from Staphylococcus
05/20/1998EP0843009A2 A human mytrophin clone hsabh01
05/20/1998EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842662A1 Percutaneous tape preparation containing fentanyl
05/20/1998EP0842269A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842195A1 Peptide inhibitors of fibronectine
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841946A1 Methods for treatment of allergic asthma
05/20/1998EP0841933A1 Bowman-birk inhibitor compositions for treatment of imflammatory disease
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841922A1 1h-4(5)-substituted imidazole derivatives
05/20/1998EP0841918A1 Thrombin inhibitors
05/20/1998EP0841910A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS
05/20/1998EP0841908A1 1,3,3-(trisubstituted)cyclohex-1-ene dimers and related compounds
05/20/1998CN1182369A Pharmaceutical compositions for controlled release of soluble receptors
05/20/1998CN1181931A Composition for transdermal delivery system containing nonsteroidal anti-inflammatory drug as active ingredient
05/19/1998US5753688 Antiinflammatory
05/19/1998US5753684 By inhibiting the uptake of urea by macrophages and its conversion to urea
05/19/1998US5753682 Imidazole lipoxygenase inhibitors
05/19/1998US5753678 Heterocyclic compounds
05/19/1998US5753657 Imidazo 1,2-A! pyrazine-4-one, preparation thereof and drugs containing same
05/19/1998US5753647 Acylamino-substituted hetrazepines
05/19/1998US5753643 Heterocyclic compounds
1 ... 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 ... 1272